Lexaria Bioscience Corp.

Quick facts

Phase 1 pipeline

• Arm 1 - DehydraTECH-CBD alone
• Arm 2 - DehydraTECH-semaglutide alone
• Arm 5- Tirzepatide · Diabetes
  GLP-1 receptor agonist

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Lexaria Bioscience Corp. portfolio CI brief
• Lexaria Bioscience Corp. pipeline updates RSS